Call Us
Erlotero- Erlotinib  Tablets 150mg

Erlotero- Erlotinib Tablets 150mg

Product Details:

X

Product Description

Erlotero- Erlotinib Tablets 150 mg are recommended for treating pancreatic cancer and non small cell lung cancer. These drugs are classified under tyrosine kinase inhibitor group of medications. Advanced formulation of these medicines effectively destroys cancer affected cells. These need to be taken on an empty stomach. Erlotero- Erlotinib Tablets 150 mg contain active ingredient erlotinib that interferes the functioning of certain abnormal protein. Standard of these tablets has been tested on the basis of their shelf life, composition, packaging type, effectiveness and possible side effects. 

 

 

Technical Specification 

 

Brand Name

Erlocip

Usage

Commercial,Hospital,Clinical

Packaging Type

Bottle

Packaging Size

1 x 30 Tablets

Form of Medicine

Tablet

No of tablets

30

Manufactured By

Cipla

Strength

150 mg

 


 


OCEAN PHARMACEUTICAL

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.
Back to top
OCEAN PHARMACEUTICAL All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.